Vascepa Approval History
FDA Approved: Yes (First approved July 26, 2012)
Brand name: Vascepa
Generic name: icosapent ethyl
Dosage form: Capsules
Company: Amarin Corporation plc
Treatment for: Hypertriglyceridemia
Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Development History and FDA Approval Process for Vascepa
|Jul 27, 2012||Amarin Announces FDA Approval of Vascepa (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.